AdvanCell Isotopes Pty Ltd

0 followers

‌

AdvanCell is an Australian radiopharmaceutical firm in the clinical stages that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.

Industries

Clinical Trials, Pharmaceutical

Employees

11-50

Links

Org chart

Andrew Adamovich

Chief Executive Officer

Andrew Adamovich

Collapse

Julian F. Kelly

Chief Scientist (Nuclear & Chemical)

Kevin Kuan

SVP Technical Operations

Nicolò Canever

Materials Development Manager

Sheridan Martin

Facilities Manager And Head Radiation Safety Officer

Simon Puttick

CSO/COO

Vanessa Worsfold

Head Of Quality And Head Of Marketing

Sheruna Naidoo

Head Of Quality And Regulatory Affairs

Michael Tung

Chief Financial Officer

Chris Horvath

Chief Commercial Officer & Chief Operating Officer

Anthony Aiudi

Board Member

Feifei Liu

Director Preclinical Science

Teams

Research and Development

8 members

Leadership Team

4 members

Similar companies

Charlie Health

5 followers

SmartTRAK

2 followers

Tessera Therapeutics

2 followers

Vaxcyte

2 followers

Septerna

2 followers

Neogene Therapeutics

2 followers

Queen Mary University

5 followers

Roche

262 followers

AbbVie

187 followers

Mirum Pharmaceuticals

3 followers

Madrigal Pharmaceuticals

1 follower

Explore companies

��������